FDA warned Leaf of Life LLC that its coca leaf powders are drugs not FDA-approved for the disease claims on its website.
What happened
In July 2022, FDA reviewed the website https://www.kokatonic.com and found it takes orders for three coca leaf powder products. FDA cited website and YouTube claims that coca leaf reduces eating anxiety, regulates blood glucose, lowers cardiovascular disease risk, regulates blood pressure, combats anemia, and relieves arthritis and osteoporosis. FDA concluded the products are unapproved new drugs (drugs not FDA-approved for those uses) and misbranded (lacking adequate directions for use).
What FDA found
FDA says the website claims make the coca leaf powders drugs intended to treat disease, but FDA has not approved them as new drugs for those uses.
FD&C Act §§ 201(p), 301(d), 505(a) [21 U.S.C. §§ 321(p), 331(d), 355(a)]FDA says the products are misbranded—labeled without adequate directions—because a layperson cannot safely use them for the claimed diseases without a licensed practitioner.
FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5FDA says shipping these misbranded drugs in interstate commerce violates the law.
FD&C Act § 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of the letter about specific steps taken to address the violations, explain how recurrence will be prevented, and include related documentation; if corrective actions cannot be completed in that time, the company must state why and when it will finish.
Who should pay attention
- online sellers of herbal powders
- brands making disease-treatment claims for botanicals
- companies selling imported coca leaf products
This is a summary. Read the original letter on fda.gov.